Research Alliance Corp IV Completes IPO, Raises $75M

What Happened

• Research Alliance Corp IV announced that its registration statement was declared effective and that it consummated an initial public offering (IPO) on July 14, 2026. The Company sold 7,500,000 Class A ordinary shares at $10.00 per share, generating $75,000,000 gross proceeds.
• Simultaneously, the Sponsor purchased 275,000 Class A shares in a private placement at $10.00 per share for $2,750,000. As of July 14, 2026, $75,000,000 of the net proceeds (including the underwriter’s deferred commission of $2,250,000) were deposited in a trust account held by Continental Stock Transfer & Trust Company. The underwriting was managed by Leerink Partners LLC.
• In connection with the offering (all dated July 10, 2026), the Company entered into the underwriting agreement, an investment management trust agreement, registration and shareholder rights agreement, indemnity agreements, a letter agreement with the Sponsor and officers/directors, and the private placement purchase and indemnification agreements. The Company also adopted its Amended and Restated Memorandum and Articles of Association and issued a press release on July 13, 2026 announcing IPO pricing.

Key Details

• IPO: 7,500,000 Class A shares at $10.00 per share; $75,000,000 gross proceeds.
• Private placement: 275,000 Class A shares to Sponsor for $2,750,000 (Section 4(a)(2) transaction).
• Trust deposit: $75,000,000 of net proceeds (including $2,250,000 underwriter deferred commission) held in trust for public shareholders.
• Board changes: Alan Musso and John Maslowski were appointed to the board (July 10, 2026); each received 30,000 Class B ordinary shares from the Sponsor in June 2026 as director compensation.

Why It Matters

• The filing confirms the Company is funded and structured to pursue an initial business combination: substantial IPO proceeds are held in a trust account for the benefit of public shareholders and the Sponsor has provided follow-on capital via the private placement.
• Investors should note the governance and contractual framework put in place (underwriting, trust agreement, registration/shareholder rights, indemnities, and voting/transfer restrictions) that govern the Sponsor, directors and the use of proceeds. These documents affect shareholder protections, registration rights, transfer restrictions and the timeline/conditions around the Company’s planned initial business combination.